Levobupivacaine Kabi

Levobupivacaine Hydrochloride, the active ingredient in Levobupivacaine Kabi, is a local anesthetic presented as a sterile solution for epidural, infiltration, intrathecal and peripheral nerve block use. It provides surgical anesthesia and postoperative or labor analgesia in adult patients.

GNH USA supplies Levobupivacaine Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levobupivacaine is a long‑acting amide local anesthetic used in the management of pain associated with surgical and obstetric procedures.

Surgical anesthesia: provides dense sensory block for operative procedures. Postoperative analgesia: extends pain relief after surgery, reducing opioid requirement. Labor analgesia: offers effective neuraxial analgesia during childbirth.

Adverse reactions may occur following administration of levobupivacaine.

Common Side Effects: - Hypotension: transient drop in blood pressure. - Bradycardia: slowed heart rate. - Dizziness or light‑headedness. - Nausea or vomiting. - Metallic taste or oral paraesthesia. - Injection site pain or irritation.

Serious or Rare Side Effects: - Cardiac arrhythmias or conduction disturbances. - Seizures, especially with high plasma concentrations. - Respiratory depression or apnea. - Allergic reactions including rash, urticaria, or anaphylaxis. - Methemoglobinemia. - Central nervous system toxicity presenting as tinnitus or visual disturbances.

Careful patient assessment and monitoring are essential when using levobupivacaine. - Hepatic impairment: reduce dose and monitor plasma levels. - Known hypersensitivity: avoid use in patients with documented allergy to amide local anesthetics. - Cardiovascular status: monitor heart rate and blood pressure during administration. - Obstetric patients: use the lowest effective dose for labor analgesia. - Concomitant CNS depressants: observe for enhanced sedation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Levobupivacaine may interact with other drugs, influencing safety and efficacy.

Major Interactions (Avoid): - Other local anesthetics: risk of cumulative toxicity. - Potent CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): increase plasma concentrations. - Drugs lowering seizure threshold (e.g., bupropion, tramadol): heighten risk of seizures.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may exacerbate bradycardia. - Vasodilators: can enhance hypotensive effects. - Anticoagulants/antiplatelet agents: increase bleeding risk with neuraxial techniques. - Diuretics: may affect plasma protein binding. - General anesthetics: monitor for additive CNS depression.